SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer

Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence worldwide, opening the discussion about the need for screening. However, no established screening tool currently exists for RC. To tackle this issue, we assessed surface-enhanced Raman scattering (SERS) profiling...

Descripción completa

Detalles Bibliográficos
Autores principales: Moisoiu, Tudor, Iancu, Stefania D., Burghelea, Dan, Dragomir, Mihnea P., Iacob, Gheorghita, Stefancu, Andrei, Cozan, Ramona G., Antal, Oana, Bálint, Zoltán, Muntean, Valentin, Badea, Radu I., Licarete, Emilia, Leopold, Nicolae, Elec, Florin I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869590/
https://www.ncbi.nlm.nih.gov/pubmed/35203443
http://dx.doi.org/10.3390/biomedicines10020233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869590/
https://www.ncbi.nlm.nih.gov/pubmed/35203443
http://dx.doi.org/10.3390/biomedicines10020233

Ejemplares similares